The role of aspirin in cardiovascular diseases--forgotten benefits?

Expert Opinion on Pharmacotherapy
Adam Williams, Charles H Hennekens

Abstract

The increasing burden of cardiovascular diseases in developed, as well as developing countries, underscores the need for the more widespread and appropriate use of aspirin in secondary prevention of occlusive vascular events during acute evolving myocardial infarction (MI) and in primary prevention. Aspirin should be far more widely used in a wide range of patients who have suffered a prior occlusive vascular event and in all patients suffering acute MI or occlusive stroke. Finally, in primary prevention, aspirin should be considered for individuals whose 10-year risks of a coronary event are > or = 10%, as an adjunct not alternative to the management of other risk factors. The more widespread and appropriate use of aspirin will avoid many premature deaths in secondary prevention and MIs in primary prevention.

References

Jul 1, 1978·Circulation·C H HennekensB Rosner
May 3, 1975·British Medical Journal·E C Hammond, L Garfinkel
May 1, 1976·British Medical Journal·H Jick, O S Miettinen
Jul 24, 1991·JAMA : the Journal of the American Medical Association·J E MansonC H Hennekens
Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Jan 30, 1988·British Medical Journal·R PetoS Norton
Apr 7, 1988·The New England Journal of Medicine·C H HennekensR Doll
Mar 9, 1974·British Medical Journal
Nov 28, 1996·The New England Journal of Medicine·C H HennekensJ E Buring
Apr 3, 1997·The New England Journal of Medicine·P M RidkerC H Hennekens
Jan 16, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Jun 21, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·Patricia R HebertCharles H Hennekens
Sep 25, 2003·Archives of Internal Medicine·Rachel S EidelmanCharles H Hennekens

❮ Previous
Next ❯

Citations

Aug 4, 2012·Journal of Medicinal Food·Iryna VoloshynaAllison B Reiss
May 1, 2006·Future Cardiology·Udaya S TantryPaul A Gurbel
Oct 8, 2005·Journal of Cardiovascular Pharmacology and Therapeutics·Victor L SerebruanyCharles H Hennekens
May 30, 2006·Nature Reviews. Drug Discovery·Joseph A Baur, David A Sinclair
Dec 22, 2007·Expert Review of Cardiovascular Therapy·Charles H Hennekens, Wendy R Schneider
Mar 19, 2013·The American Journal of Medicine·Charles H Hennekens, James E Dalen
May 11, 2021·BioMed Research International·Xiaolong WuMingming Xue
Nov 10, 2009·Biochimica Et Biophysica Acta·Joseph A Baur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.